Dr. Jeffrey L. Cummings

Research Professor, Department of Brain Health
Director, Chambers-Grundy Center for Transformative Neuroscience at UNLV
Expertise: Neuroscience, neurodegenerative diseases, Alzheimer’s Disease, drug development, clinical trials, neurotherapeutics

Biography

Jeffrey L. Cummings, MD, ScD, joined the UNLV School of Integrated Health Sciences in 2019 as research professor within the department of brain health. Dr. Cummings is the Joy Chambers-Grundy Professor of Brain Science, an endowed professorship. He is the Director of the Chambers-Grundy Center for Transformative Neuroscience, a center devoted to using the tools of neuroscience and neurologic drug development to transform people’s lives.

Prior to UNLV, Dr. Cummings served as founding director of the Cleveland Clinic Lou Ruvo Center for Brain Health in Las Vegas, and as director of the Mary S. Easton Center for Alzheimer’s Disease Research, and director of the Deane F. Johnson Center for Neurotherapeutics, both at UCLA.

A world-renowned Alzheimer’s researcher and leader of clinical trials, Dr. Cummings has been recognized for his scientific and leadership contributions with the American Geriatrics Society’s Henderson Award (2006), the national Alzheimer’s Association’s Ronald and Nancy Reagan Research Award (2008), and the American Association of Geriatric Psychiatry’s Distinguished Scientist Award (2010). 

Dr. Cummings’ interests embrace clinical trials, developing new therapies for brain diseases, and the interface of neuroscience and society. Dr. Cummings has published nearly 800 articles and 44 books devoted to neuroscience, Alzheimer’s disease, and clinical trials.

Dr. Cummings received the Society for Behavioral and Cognitive Neurology’s Lifetime Achievement Award (2017), the International Society of CNS Drug Development’s Leadership and Achievement Award and the national Alzheimer’s Association’s Bengt Winblad Lifetime Achievement Award (2018).

Additionally, he was featured in Gentleman’s Quarterly (June 2009) as a “Rock Star of Science. ™” In addition to his work at UNLV, Dr. Cummings is professor of medicine (Neurology) at Cleveland Clinic Lerner College of Medicine at Case Western Reserve University, and he is principal investigator/director of the National Institute of General Medical Sciences-funded Center for Neurodegeneration and Translational Neuroscience.

Education

  • Sc.D., Science, University of Wyoming
  • Neurology fellowship, Boston University School of Medicine
  • Neuropathology/Neuropsychiatry fellowship, National Hospital for Nervous Diseases, London
  • M.D., Medicine, University of Washington
  • B.S., Zoology/Philosophy, University of Wyoming

Search For Other Experts On

health & medicine, science & technology

Dr. Jeffrey L. Cummings In The News

HCP Live
April 19, 2021
A new study endeavor will explore US Food and Drug Administration (FDA) approved medications for efficacy in Alzheimer disease.
Business Insider
March 29, 2021
In the US, about 6.2 million people have Alzheimer's disease. About 70% experience agitation — extreme emotional distress that can manifest as resisting care, shouting, or becoming physically violent — and 40% have symptoms severe enough to require treatment, Dr. Jeffrey Cummings told Insider. But there isn't a single approved drug to treat agitation in people with Alzheimer's.
LABIOTECH.eu
December 21, 2020
Last week, AB Science reported successful results from a phase IIb/III clinical trial testing its drug masitinib in patients with mild to moderate symptoms of Alzheimer’s.
Market Screener
December 16, 2020
AB Science SA (NYSE Euronext – FR0010557264 – AB) will host a live webcast on December 17, 2020 with key opinion leaders to discuss recently reported results from the Phase 2B/3 masitinib trial in Alzheimer’s Disease.

Articles Featuring Dr. Jeffrey L. Cummings

Dr. Jeffrey Cummings is pictured in a white lab coat in his lab, with his image reflected in a mirror
Campus News | April 16, 2021
Dr. Jeffrey Cummings and multidisciplinary research team to expand UNLV’s clinical trials observatory with $3 million grant.
Professor Ashkan Salamat in his lab at UNLV
Research | December 29, 2020
A yearlong collection of UNLV faculty making the news for their discoveries and contributions to the community.
A portrait of UNLV's new president Keith Whitfield on campus.
Campus News | August 10, 2020
As summer heats up, so do the accomplishments on UNLV’s campus.
A UNLV banner on campus.
Campus News | July 2, 2020
A collection of news stories featuring the people and programs of UNLV.